Indirect costs of cervical and breast cancers in Spain

Eur J Health Econ. 2005 Dec;6(4):309-13. doi: 10.1007/s10198-005-0303-4.

Abstract

This study estimated the indirect costs (productivity loss) caused by mortality and morbidity of cervical and breast cancers in Spain. We used two alternative methods: (a) the traditional human capital (HC) approach and (b) the friction cost (FC) method. The annual costs were Euro 43.4 and 288.7 for cervical and breast cancer, respectively, by the HC approach and Euro 1.1 and 11.6 million by the FC approach. Cost-of-illness studies help to illustrate the real dimension of health problems and should be a major concern for health policies. Indirect costs are relevant information about diseases. However, the estimated indirect costs depend heavily on the approach adopted.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Distribution
  • Breast Neoplasms / economics*
  • Breast Neoplasms / epidemiology*
  • Breast Neoplasms / mortality
  • Cost of Illness*
  • Disability Evaluation
  • Efficiency*
  • Employment / economics*
  • Female
  • Health Priorities
  • Humans
  • Middle Aged
  • Registries
  • Spain / epidemiology
  • Uterine Cervical Neoplasms / economics*
  • Uterine Cervical Neoplasms / epidemiology*
  • Uterine Cervical Neoplasms / mortality
  • Women's Health*